Bill

Bill > S1760


FL S1760

FL S1760
Health Care Coverage


summary

Introduced
01/13/2026
In Committee
01/16/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

An act relating to health care coverage; amending s. 1.01, F.S.; defining the term “Joint Legislative Committee on Medicaid Oversight”; creating s. 11.405, F.S.; establishing the Joint Legislative Committee on Medicaid Oversight for specified purposes; providing for membership, subcommittees, and meetings of the committee; specifying duties of the committee; authorizing the committee to submit periodic reports to the Legislature; requiring the Auditor General and the Agency for Health Care Administration to enter into and maintain a data sharing agreement for a certain purpose by a specified date; requiring the Auditor General to assist the committee by providing certain staff or consulting services; requiring that state agencies, political subdivisions of the state, and entities contracted with state agencies give the committee access to certain records, papers, and documents; authorizing the committee to compel testimony and evidence according to specified provisions; providing for additional powers of the committee; providing that certain joint rules of the Legislature apply to the proceedings of the committee; requiring the agency to notify the committee of certain changes and provide a report containing specified information to the committee; requiring the agency to submit a copy of certain reports to the committee; amending s. 409.962, F.S.; defining terms; amending s. 409.967, F.S.; revising encounter data reporting requirements for prepaid Medicaid plans; requiring the agency’s analysis of such encounter data to include identification of specified occurrences; requiring the agency to use such analysis in setting managed care plan capitation rates; requiring that managed care plan contracts require any third-party administrative entity contracted with the plan to adhere to specified requirements; specifying additional types of payments which may not be included in calculating income for purposes of the achieved savings rebate; requiring, rather than authorizing, the agency to calculate the medical loss ratio for all managed care plans under certain circumstances; revising requirements for the calculation of medical loss ratios; requiring the agency to report medical loss ratios quarterly and annually for each managed care plan to the Governor and the Legislature within a specified timeframe; requiring the agency to ensure oversight of affiliated entities and related parties paid by managed care plans; requiring the agency to examine specified records and data related to such entities and parties; requiring the agency to consider certain data and findings when developing managed care plan capitation rates; revising the income sharing ratios used to calculate the achieved savings rebate beginning on a specified date; creating s. 409.9675, F.S.; requiring managed care plans to report to the agency and the Office of Insurance Regulation the existence of and specified details relating to certain affiliations by a specified date and annually thereafter; requiring managed care plans to report any change in such information to the agency and the office in writing within a specified timeframe; requiring the agency to calculate, analyze, and publicly report on the agency’s website an assessment of affiliated entity payment transactions in the Medicaid program and certain administrative costs by a specified date and annually thereafter; providing requirements for the assessment; amending s. 626.8825, F.S.; defining the terms “affiliated manufacturer” and “covered prescription drug”; revising the definition of the term “pharmacy benefits plan or program”; revising requirements for contracts between a pharmacy benefit manager and a pharmacy benefits plan or program and a participating pharmacy; revising the frequency of and deadlines for certain reports pharmacy benefit managers are required to submit to the office beginning on a specified date; amending s. 626.8827, F.S.; revising and specifying additional practices pharmacy benefit managers are prohibited from engaging in; amending s. 627.42392, F.S.; conforming a cross-reference; providing effective dates.

AI Summary

This bill establishes a Joint Legislative Committee on Medicaid Oversight, comprised of five senators and five representatives, to ensure the Medicaid program operates efficiently and transparently, with duties including evaluating program financing, quality of care, and administrative functions, and identifying policies to control spending while improving outcomes. The committee will have access to state agency records and can compel testimony, and the Auditor General will assist with staff and consulting services. The bill also revises requirements for managed care plans, including how they report encounter data (information on services provided to Medicaid recipients), how their financial performance is analyzed, and how capitation rates (fixed payments per person) are set, with a focus on identifying potential overspending on administrative costs and inappropriate service utilization. It introduces new definitions for "affiliate" and "control" to better track relationships between managed care plans and other entities, and requires managed care plans to report details about their affiliations and any business transactions with affiliated entities. Furthermore, the bill strengthens oversight of affiliated entities and related parties paid by managed care plans, requiring the agency to consider this data when setting capitation rates, and modifies how "achieved savings rebates" (incentives for plans that reduce costs) are calculated by excluding payments to affiliates above market rates. The bill also mandates quarterly and annual reporting of "medical loss ratios" (the percentage of premium revenue spent on healthcare services) for managed care plans and introduces new reporting requirements for pharmacy benefit managers (companies that manage prescription drug benefits) regarding their affiliations, prohibited practices, and reporting of appeals related to drug pricing, aiming to increase transparency and accountability within the healthcare system.

Committee Categories

Budget and Finance

Sponsors (4)

Other Sponsors (1)

Health Policy (Senate)

Last Action

CS by Health Policy read 1st time (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...